Skip to main content
. 2023 May 2;13(5):e070189. doi: 10.1136/bmjopen-2022-070189

Table 1.

Clinical and biochemical characteristics of the MAFLD and non-MAFLD groups

MAFLD Non-MAFLD P value
N (%) 8099 (38.71%) 12 823 (61.29%) <0.0001
Male (%) 6152 (75.96%) 6191 (48.29%) <0.0001
Age (years) 46.91±12.57 42.16±12.65 <0.0001
SBP (mm Hg) 131.97±17.47 120.11±16.60 <0.0001
DBP (mm Hg) 81.53±11.90 73.51±10.97 <0.0001
BMI (kg/m2) 27.14±2.90 22.69±2.65 <0.0001
 BMI<23 (%) 258 (3.50%) 7119 (96.50%) <0.0001
 23≤BMI<25 (%) 1598 (33.30%) 3201 (66.70%) <0.0001
 BMI≥25 (%) 6244 (71.40%) 2502 (28.60%) <0.0001
WC (cm) 90.44±8.46 77.16±9.06 <0.0001
 WCmale 92.38±7.73 82.84±7.46 <0.0001
 WCfemale 84.06±7.62 71.85±6.98 <0.0001
TyG 7.44±0.61 6.77±0.53 <0.0001
TyG-BMI 202.04±28.85 154.16±24.91 <0.0001
TyG-WC 673.57±90.67 524.59±87.49 <0.0001
 TyG-WCmale 692.52±86.67 577.04±77.69 <0.0001
 TyG-WCfemale 612.49±76.61 475.47±64.79 <0.0001
ALT (U/L) 26 (18,38) 15 (11,21) <0.0001
AST (U/L) 22 (18,27) 18 (16,22) <0.0001
GGT (U/L) 32 (22,49) 17 (13,25) <0.0001
BUN (mmol/l) 5.15±1.24 4.84±1.26 <0.0001
Cr (µmol/l) 66.43±13.07 66.49±13.07 0.731
UA (µmol/l) 354.36±84.81 290.96±76.54 <0.0001
FPG (mmol/l) 5.29 (4.93,5.78) 4.98 (4.71,5.29) <0.0001
TG (mmol/l) 4.78±0.96 4.45±0.87 <0.0001
TC (mmol/l) 1.83 (1.31,2.63) 1.03 (0.76,1.43) <0.0001
HDL-C (mmol/l) 1.19±0.26 1.38±0.30 <0.0001
LDL-C (mmol/l) 3.13±0.73 2.84±0.69 <0.0001

Data are expressed as mean±SD or medians (IQRs) for skewed variables or numbers (proportions) for categorical variables.

ALT, alanine aminotransferase; AST, aspartate transaminase; BMI, body mass index; BUN, blood urea nitrogen; Cr, creatinine; DBP, diastolic blood pressure; FPG, fasting plasma glucose; GGT, γ‐glutamyltransferase; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MAFLD, metabolic-associated fatty liver disease; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; TyG, triglyceride glucose; UA, uric acid; WC, waist circumference.